2018-10-31T15:46:52-05:00 2017-12-31 061671819 PKF O'CONNOR DAVIES LLP 665 FIFTH AVENUE NEW YORK NY 10022 990 2017-01-01 133299366 AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE AMER 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO PRESIDENT/CEO 2125665555 2018-10-31 1 GARRETT M HIGGINS P00543209 2122862600 2018-10-22 4.15.211.182 2018-10-31 15:26:37 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 B29914CEB47F2C50F9800CDE5B5AE22990D509AB 2017 2019-02-21 02:37:17Z AATOD MARK W PARRINO 225 VARICK STREET 4TH FL NEW YORK NY 10014 761542 0 X WWW.AATOD.ORG X 1984 NY TO ENHANCE THE QUALITY OF PATIENT CARE IN COMPREHENSIVE OPIOID TREATMENT PROGRAMS. 32 31 5 36 0 0 478754 97072 1598589 662824 38 1 249 1645 2077630 761542 0 0 0 0 439783 458280 0 0 54490 1339760 576300 1779543 1034580 298087 -273038 680372 794092 259173 645931 421199 148161 THE AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE ("AATOD") WAS FOUNDED IN 1984 TO ENHANCE THE QUALITY OF PATIENT CARE IN TREATMENT PROGRAMS BY PROMOTING THE GROWTH AND DEVELOPMENT OF COMPREHENSIVE OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES. 0 0 570335 662824 RX OPIOID STUDY- TO BETTER UNDERSTAND THE IMPACT OF PRESCRIPTION OPIOID USE ON ADMISSIONS TO OPIOID TREATMENT PROGRAMS. SEVENTY FIVE TREATMENT PROGRAMS PROVIDE TREND ANALYSIS DATA. 65426 OTPS STUDY- TO INCREASE ACCESS TO THE TREATMENT OF OPIOID ADDICTION THROUGH OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES OF AMERICA. 635761 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 5 1 0 0 0 0 0 0 0 0 0 0 X 32 31 0 0 1 0 1 0 0 1 1 0 0 1 1 0 0 0 0 1 0 0 NY X X MARK PARRINO 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO MPA PRESIDENT/CEO 40.00 X X 180000 0 20803 JANICE F KAUFFMAN FIRST V.P. 1.00 X X 0 0 0 GEORGE E STAVROS SECOND V.P. 1.00 X X 0 0 0 MICHAEL RIZZI TREASURER 1.00 X X 0 0 0 TINA BECKLEY SECRETARY 1.00 X X 0 0 0 RICHARD BILANGI DIRECTOR 1.00 X 0 0 0 TIM BOHMAN DIRECTOR (THRU JUNE 2017) 1.00 X 0 0 0 HOLLY BROCE DIRECTOR 1.00 X 0 0 0 ROY T BROWN DIRECTOR 1.00 X 0 0 0 MOLLY CARNEY DIRECTOR 1.00 X 0 0 0 SUSAN CASE DIRECTOR 1.00 X 0 0 0 CASSITY CONDIT-ASHER DIRECTOR (THRU MARCH 2017) 1.00 X 0 0 0 BRIAN CRISSMAN DIRECTOR 1.00 X 0 0 0 EMILIA FIGUEROA GUILLEN DIRECTOR (THRU MARCH 2017) 1.00 X 0 0 0 CHERYL L GARDINE DIRECTOR 1.00 X 0 0 0 GLORIA HANANIA DIRECTOR 1.00 X 0 0 0 KEITH HOCHADEL DIRECTOR 1.00 X 0 0 0 EDWARD J HIGGINS DIRECTOR 1.00 X 0 0 0 KENNY HOUSE DIRECTOR 1.00 X 0 0 0 ANN JAMIESON DIRECTOR 1.00 X 0 0 0 JASON KLETTER DIRECTOR 1.00 X 0 0 0 BRETT LECHLEITNER DIRECTOR 1.00 X 0 0 0 SHIRLEY LINZY DIRECTOR 1.00 X 0 0 0 KATE MAHONEY DIRECTOR (THRU MARCH 2017) 1.00 X 0 0 0 CHRISTINE MARTIN DIRECTOR 1.00 X 0 0 0 BRIAN MCCARROLL DIRECTOR 1.00 X 0 0 0 PAUL MCLAUGHLIN DIRECTOR 1.00 X 0 0 0 JENNIFER MINTHORN DIRECTOR (THRU MARCH 2017) 1.00 X 0 0 0 EDWARD V OHLINGER DIRECTOR 1.00 X 0 0 0 STACEY PEARCE DIRECTOR 1.00 X 0 0 0 ALLEGRA SCHORR DIRECTOR 1.00 X 0 0 0 KENNETH STOLLER MD DIRECTOR 1.00 X 0 0 0 HELENE K MURPHY DIRECTOR 1.00 X 0 0 0 ARTURO VALDEZ DIRECTOR 1.00 X 0 0 0 BRIAN GOODLETT DIRECTOR (AS OF SEP. 2017) 1.00 X 0 0 0 ERIN LACOURT DIRECTOR (AS OF SEP. 2017) 1.00 X 0 0 0 JOANNA BAEZ DIRECTOR (AS OF SEP. 2017) 1.00 X 0 0 0 180000 0 20803 1 0 1 0 NATIONAL DEVELOPMENT AND RESEARCH INSTIT 71 WEST 23RD STREET 8TH FL NEW YORK NY 10010 DATA MANAGEMENT AND ANALYSIS 237443 1 97072 97072 RX OPIOID STUDY 900099 533994 533994 MEMBERSHIP DUES 900099 128830 128830 662824 1 1 MISCELLANEOUS 900099 1645 1645 1645 761542 662824 0 1646 X 200803 87687 93678 19438 185501 81167 86378 17956 5842 2501 2775 566 39998 17126 19000 3872 26136 11191 12415 2530 30065 14354 12536 3175 237443 237443 46256 40913 4374 969 11469 4240 6290 939 116770 34161 82609 7096 3105 3304 687 30325 13168 14244 2913 4053 1773 1888 392 1133 495 528 110 4895 2142 2279 474 PROGRAM INCENTIVES 82170 82170 MISCELLANEOUS 4625 2125 2031 469 1034580 635761 344329 54490 108407 224742 346 346 165238 96079 391551 466711 13665 6182 24971 24939 1165 32 680372 794092 109226 48056 15923 478716 50990 25198 83034 93961 259173 645931 X 404858 117246 16341 30915 421199 148161 680372 794092 -273038 0 X X 0 1 X 1 0 X 224500 28865 239466 341419 97072 931322 1403049 695559 1649027 1735924 662824 6146383 1627549 724424 1888493 2077343 759896 7077705 0 453664 491715 535194 546194 526379 2553146 453664 491715 535194 546194 526379 2553146 4524559 7 15 33 287 1 343 7 15 33 287 1 343 12000 5141 5479 1645 24265 1639556 729580 1894005 2077630 761542 7102313 0.63710 0.68060 0.00000 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2013 AMOUNT: $ 12,000. 2014 AMOUNT: $ 5,141. 2015 AMOUNT: $ 5,479. 2017 AMOUNT: $ 1,645. 5150 5118 32 19821 19821 0 32 DEFERRED RENT 93961 93961 X 761542 0 761542 0 761542 1034580 0 1034580 0 1034580 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2014. X X X 0 0 0 0 0 0 0 0 0 MARK W PARRINO MPA PRESIDENT/CEO 180000 0 0 0 0 0 8500 0 12303 0 200803 0 0 0 FORM 990, PART VI, SECTION A, LINE 4 THE FOLLOWING SIGNIFICANT ADDITIONS AND CHANGES HAVE BEEN MADE TO THE ORGANIZATION'S BY-LAWS: ARTICLE V - MEMBERSHIP 1) UPON COMPLETING THE REQUIREMENTS FOR MEMBERSHIP AN ASSOCIATION CAN FILE AN APPLICATION FOR MEMBERSHIP IN THE AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE, INC. FOR THE PURPOSE OF THESE BY-LAWS, A STATE ASSOCIATION WILL BE CONSIDERED AN ENTITY IF COMPRISED OF A MINIMUM OF THREE (3) INDEPENDENTLY OWNED PROVIDERS. THE MEMBERSHIP COMMITTEE WILL EVALUATE ALL APPLICATIONS AND MAKE RECOMMENDATIONS TO THE BOARD OF DIRECTORS. UPON APPROVAL BY THE BOARD OF DIRECTORS AND UPON PAYMENT OF THE DESIGNATED ANNUAL DUES THE STATE OR COUNTRY SHALL BECOME A MEMBER OF THE AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE, INC. 2) IN ADDITION TO STATE AND COUNTRY MEMBERSHIP IN THE ASSOCIATION, THE BOARD MAY INCLUDE UP TO THREE (3) MEMBERS-AT-LARGE. THE PRESIDENT OF THE ASSOCIATION MAY NOMINATE INDIVIDUALS WITH DEMONSTRATED EXPERTISE IN THE FIELD OF MEDICATION ASSISTED TREATMENT, LAW, POLICY, HEALTHCARE OR OTHER DISCIPLINES RELATED TO THE GOALS OF THE ASSOCIATION TO THE MEMBERSHIP COMMITTEE FOR CONSIDERATION AS A MEMBER-AT-LARGE OF THE BOARD OF DIRECTORS. THE MEMBERSHIP COMMITTEE WOULD REVIEW SUCH APPLICATIONS AND MAKE RECOMMENDATIONS TO THE BOARD. MEMBERS-AT-LARGE SHALL HAVE VOTING PRIVILEGES AND SERVE A FOUR-YEAR TERM. 3) MEMBER STATES OR COUNTRIES SHALL COMMIT TO SELECTING A REPRESENTATIVE TO SERVE ON THE BOARD OF DIRECTORS FOR A MINIMUM OF FOUR (4) CONSECUTIVE YEARS. IF FOR ANY REASON THE APPOINTEE IS UNABLE TO COMPLETE THEIR TERM, THE MEMBER STATE OR COUNTRY SHALL APPOINT A REPLACEMENT. THE EXPECTATION OF THE BOARD OF DIRECTORS IS THAT INDIVIDUAL REPRESENTATIVES WILL SERVE THE COMPLETE TERM. ARTICLE VIII - VOTING 1) A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS SHALL CONSTITUTE A QUORUM FOR THE TRANSACTION OF BUSINESS OF ANY SPECIFIED ITEM OF BUSINESS. 2) AN AFFIRMATIVE VOTE BY A MAJORITY OF THE DIRECTORS PRESENT AND VOTING AT A MEETING OF THE BOARD OF DIRECTORS AT THE TIME OF SUCH VOTE, IF A QUORUM IS THEN PRESENT, SHALL BE THE ACT OF THE BOARD OF DIRECTORS, UNLESS A GREATER PROPORTION IS REQUIRED BY THE ARTICLES OF INCORPORATION, THESE BYLAWS OR APPLICABLE LAW. ARTICLE XI - BOARD OF DIRECTORS 1) THE BOARD OF DIRECTORS OF THE ASSOCIATION SHALL DIRECT THE AFFAIRS OF THE ASSOCIATION. THE BOARD OF DIRECTORS SHALL APPROVE GOALS AND STRATEGIES TO BE ACCOMPLISHED, MONITOR THE ACHIEVEMENT OF THE GOALS AND STRATEGIES, ALLOCATE THE NECESSARY RESOURCES TO ACHIEVE THE GOALS AND STRATEGIES AND MONITOR THAT THE RESOURCES ARE USED EFFICIENTLY AND EFFECTIVELY. THE BOARD OF DIRECTORS SHALL BE VESTED WITH THE POWERS POSSESSED BY THE CORPORATION ITSELF INCLUDING THE POWER TO DETERMINE THE POLICIES OF THE CORPORATION; TO PROSECUTE IT'S PURPOSES; TO DISBURSE THE FUNDS OF THE CORPORATION AND TO ADOPT SUCH RULES AND REGULATIONS FOR THE CONDUCT OF ITS BUSINESS, RESPONSIBILITY AND AUTHORITY AS SHALL BE DEEMED ADVISABLE, INSOFAR AS SUCH DELEGATION OF AUTHORITY IS NOT INCONSISTENT WITH OR REPUGNANT TO THE ARTICLES OF INCORPORATION OR BYLAWS OF THE ASSOCIATION (IN THEIR PRESENT FORM OR AS THEY MAY BE AMENDED) OR TO ANY APPLICABLE LAW OF THE STATE OF NEW YORK. 2) THE BOARD OF DIRECTORS OF THE ASSOCIATION SHALL BE COMPOSED OF ONE (1) DIRECTOR FROM EACH MEMBER STATE OR COUNTRY, WHICH DIRECTOR SHALL BE SELECTED IN ACCORDANCE WITH THE BYLAWS OF THE RESPECTIVE STATE OR COUNTRY ASSOCIATION. ADDITIONALLY, THE BOARD MAY ELECT UP TO THREE (3) MEMBERS-AT-LARGE. ARTICLE XIII - OFFICERS 1) THE OFFICERS OF THE CORPORATION SHALL BE PRESIDENT, FIRST VICE PRESIDENT, SECOND VICE PRESIDENT, SECRETARY AND TREASURER. 2) FIRST VICE PRESIDENT. THE FIRST VICE PRESIDENT SHALL HAVE SUCH POWERS AND DUTIES AS THE BOARD OF DIRECTORS MAY DIRECT OR AS ARE REASONABLY INCIDENTAL TO SUCH OFFICE. THE FIRST VICE PRESIDENT SHALL, IN THE ABSENCE OR DISABILITY OF THE PRESIDENT, EXERCISE THE POWERS AND PERFORM THE DUTIES OF THE PRESIDENT. 3) SECOND VICE PRESIDENT. THE SECOND VICE PRESIDENT SHALL HAVE SUCH POWERS AND DUTIES AS THE BOARD OF DIRECTORS MAY DIRECT OR AS ARE REASONABLY INCIDENTAL TO SUCH OFFICE. THE SECOND VICE PRESIDENT SHALL, IN THE ABSENCE OR DISABILITY OF BOTH THE PRESIDENT AND THE FIRST VICE PRESIDENT, EXERCISE AND PERFORM THE DUTIES OF THE PRESIDENT. ARTICLES XIV - COMMITTEES 1) THE BOARD OF DIRECTORS IS AUTHORIZED TO CREATE COMMITTEES TO FOCUS ON ISSUES THE BOARD DEEMS APPROPRIATE. THE BOARD SHALL SPECIFY THE PURPOSE AND COMPOSITION OF COMMITTEES. THE PRESIDENT SHALL APPOINT THE CHAIR OF SUCH COMMITTEES. THE CHAIR OF THE VARIOUS COMMITTEES WILL SELECT COMMITTEE MEMBERS FROM CURRENT MEMBERS OF THE BOARD OF DIRECTORS. ALL COMMITTEES SHOULD HAVE NO FEWER THAN THREE (3) MEMBERS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION OFFERS STATE MEMBERSHIP TO ORGANIZATIONS IN THE MEDICATION ASSISTED TREATMENT FIELD. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE PRESIDENT, FISCAL MANAGER, THE TREASURER, AND FINANCE COMMITTEE BEFORE FILING. THE FINAL FORM 990 IS PROVIDED TO THE FULL BOARD OF DIRECTORS BEFORE E-FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, ACTING AS THE COMPENSATION COMMITTEE, CONDUCTS ANNUAL REVIEWS OF THE PRESIDENT'S PERFORMANCE AND COMPENSATION. EVERY THIRD YEAR THE EXECUTIVE COMMITTEE REVIEWS COMPARABILITY DATA AND SETS NEW COMPENSATION LEVELS TO BE REFLECTED IN THE PRESIDENT'S THREE YEAR CONTRACT. THE CONTRACT AS PROPOSED BY THE EXECUTIVE COMMITTEE IS THEN SUBMITTED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THIS PROCESS LAST OCCURED IN 2017. ALL DECISIONS WERE DOCUMENTED IN THE MINUTES OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, AATOD MAKES AVAILABLE TO THE PUBLIC ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS. FORM 990, PART IX, LINE 11G DATA MANAGEMENT AND ANALYSIS: PROGRAM SERVICE EXPENSES 237,443. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 237,443. FORM 990, PART XII, LINE 2C: AATOD HAS A FINANCE COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT AUDITOR. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.